Navigation Links
Mother's postpartum oxycodone use: No safer for breastfed infants than codeine

Cincinnati, OH, September 6, 2011 -- Doctors have been prescribing codeine for postpartum pain management for many years, and, until recently, it was considered safe to breastfeed while taking the opioid. But the death of an infant exposed to codeine through breast milk has many health care providers questioning the safety of the drug when used by breastfeeding mothers. Because of the potential risks, some doctors have begun the practice of prescribing oxycodone as an alternative to codeine; however, a new study soon to be published in The Journal of Pediatrics finds that oxycodone is no safer for breastfed infants than codeine.

To estimate the risks to babies breastfed by mothers taking either codeine or oxycodone, Dr. Gideon Koren of The Hospital for Sick Children (SickKids) in Toronto, and colleagues from institutions in both Canada and The Netherlands, pooled data from the Motherisk Program, a Teratology Information Center at SickKids that counsels women about the safety of using medication during pregnancy and breastfeeding. The researchers surveyed 533 women who had contacted the program with questions about using acetaminophen, codeine, or oxycodone for pain management while breastfeeding.

The mothers were asked to report their experiences with central nervous system (CNS) depression, as well as those of their infants, during the time they were taking one of the drugs and breastfeeding. According to Dr. Koren, "Typical symptoms of CNS depression include sleepiness, lethargy, and in the infant's case trouble breastfeeding." Of the 210 mothers who took codeine while breastfeeding, 16.7% reported symptoms of CNS depression in their child. Moreover, 20% of the 139 mothers who took oxycodone described these symptoms in their child. In contrast, only 0.5% of the 184 women who took acetaminophen while breastfeeding reported symptoms of CNS depression in their child. Additionally, mothers of symptomatic infants who took either codeine or oxycodone were significantly more likely to report CNS depression symptoms in themselves.

"The strong concordance between maternal and infant symptoms may be used to identify babies at higher risk of CNS depression," Dr. Koren notes. He suggests that health care providers should perform follow-up examinations on breastfed babies whose mothers are receiving either codeine or oxycodone, and he stresses that these drugs "cannot be considered safe during breastfeeding in all cases."


Contact: Brigid Huey
Elsevier Health Sciences

Related medicine news :

1. Malaria parasites camouflage themselves from the immune defenses of expectant mothers
2. Daughters Seem to Influence Mothers Fashion Sense
3. Mothers with breastfeeding difficulties more likely to suffer postpartum depression
4. Corporal punishment: Mothers self-recorded audio gives unique real-time view of spanking
5. Mothers Play Important Role in Recovery From Mental Illness
6. Successful depression treatment of mothers has long-term effects on offspring
7. Severity of hepatitis C and HIV co-infection in mothers contribute to HCV transmission to child
8. Mothers abused during childhood at risk for having low birth weight babies
9. Scheduled deliveries raise risks for mothers, do not benefit newborns
10. When first-time mothers are induced, breaking the amniotic membrane shortens delivery time
11. Childrens BMI found to rise the longer their mothers work
Post Your Comments:
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
(Date:6/24/2016)... , Belgium , June ... MKT: VNRX), today announced the appointment of Dr. ... of Directors as a Non-Executive Director, effective June ... Company,s Audit, Compensation and Nominations and Governance Committees.  ... Dr. Futcher will provide independent expertise and strategic ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
Breaking Medicine Technology: